"Our goal is to use a patient's own cells to engineer replacement tissue in the lab for devastating conditions that affect the digestive system." Sphincter Project: The lab-engineered sphincters are ...
BEIJING, Aug. 29, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results